Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2008 Oct 30;7(11):3539–3545. doi: 10.1158/1535-7163.MCT-08-0512

Figure 3.

Figure 3

PC-3 (A) and DU-145 (B) cell survival analysis by MTT assay following 48 hour treatment with 0 μM (cross-hatched), 50 μM (diagonal), or 100 μM (stippled) carprofen (Carp). Prior to treatment, cells were co-transfected with a ponasterone A-inducible ecdysone receptor plasmid pVgRxR and ΔICDp75NTR (ICD). Following transfection, cells were incubated in serum containing medium for 18 hours, and then incubated in 1 μM ponasterone A (P) for 24 hours to drive expression of the dominant negative gene products (ICD). Results are expressed relative to the control (0 μM). *, P < 0.001